Back to Search
CHARLES LERMAN, PH.D.
PH.D.
Psychologist
NPI: 1871616557Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Translational research in medication development for nicotine dependence.
PMID 17690709·Nat Rev Drug Discov·2007
6-review
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
PMID 16123753·Neuropsychopharmacology·2006
2-rct
Changes in food reward following smoking cessation: a pharmacogenetic investigation.
PMID 15138759·Psychopharmacology (Berl)·2004
3-trial
The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial.
PMID 15007373·Pharmacogenomics J·2004
3-trial
Genetic testing for cancer susceptibility: the promise and the pitfalls.
PMID 14993905·Nat Rev Cancer·2004
6-review
Effect of bupropion on depression symptoms in a smoking cessation clinical trial.
PMID 15631608·Psychol Addict Behav·2004
3-trial
Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial.
PMID 14570538·Health Psychol·2003
3-trial
Elucidating the role of genetic factors in smoking behavior and nicotine dependence.
PMID 12627466·Am J Med Genet B Neuropsychiatr Genet·2003
6-review
Pharmacogenetic investigation of smoking cessation treatment.
PMID 12439223·Pharmacogenetics·2002
3-trial
Genetic testing: psychological aspects and implications.
PMID 12090383·J Consult Clin Psychol·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 16255 VENTURA BLVD, SUITE 806
ENCINO, CA 91436 - Phone
- (818) 708-1801
Quick Facts
- NPI
- 1871616557
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile